Cooper Companies - COO Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $111.42
  • Forecasted Upside: 22.69%
  • Number of Analysts: 11
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$90.81
▲ +2.23 (2.52%)

This chart shows the closing price for COO by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cooper Companies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for COO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for COO

Analyst Price Target is $111.42
▲ +22.69% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for Cooper Companies in the last 3 months. The average price target is $111.42, with a high forecast of $125.00 and a low forecast of $88.75. The average price target represents a 22.69% upside from the last price of $90.81.

This chart shows the closing price for COO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 11 polled investment analysts is to moderate buy stock in Cooper Companies. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/22/2023
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/22/2023
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
7/21/2023
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/19/2023
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/17/2024
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/16/2024
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/15/2024
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
7/15/2024

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/3/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$115.00 ➝ $115.00Low
5/31/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$116.00 ➝ $118.00Low
5/31/2024Needham & Company LLCReiterated RatingHoldLow
5/23/2024Needham & Company LLCReiterated RatingHoldLow
4/3/2024CitigroupBoost TargetBuy ➝ Buy$108.00 ➝ $116.00Low
3/19/2024Redburn AtlanticUpgradeNeutral ➝ Buy$125.00Low
3/13/2024JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$100.00 ➝ $120.00Low
3/1/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$94.00 ➝ $100.00Low
3/1/2024Piper SandlerBoost TargetOverweight ➝ Overweight$110.00 ➝ $115.00Low
3/1/2024Stifel NicolausReiterated RatingBuy ➝ Buy$105.00 ➝ $110.00Low
3/1/2024MizuhoBoost TargetBuy ➝ Buy$102.50 ➝ $115.00N/A
2/6/2024KeyCorpInitiated CoverageSector WeightLow
1/12/2024Piper SandlerBoost TargetOverweight ➝ Overweight$107.50 ➝ $110.00Low
12/4/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$102.50 ➝ $88.75Low
11/29/2023JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$96.25 ➝ $93.75Low
10/30/2023Bank of AmericaInitiated CoverageBuy$95.00Low
10/5/2023Redburn AtlanticDowngradeBuy ➝ Neutral$97.50 ➝ $85.75Low
10/2/2023CitigroupLower Target$110.00 ➝ $105.00Low
9/28/2023Morgan StanleyInitiated CoverageEqual Weight$102.50Low
8/31/2023Stifel NicolausReiterated RatingBuy ➝ Buy$105.00Low
8/31/2023Robert W. BairdBoost TargetOutperform ➝ Outperform$100.00 ➝ $102.50Low
8/28/2023MizuhoReiterated RatingBuy ➝ Buy$110.00Low
7/17/2023MizuhoBoost Target$100.00 ➝ $110.00Low
7/10/2023CitigroupBoost Target$107.75 ➝ $110.00Low
6/2/2023Robert W. BairdBoost Target$96.25 ➝ $100.00Low
5/30/2023Morgan StanleyInitiated CoverageEqual Weight$102.50Low
5/24/2023Piper SandlerBoost Target$93.75 ➝ $107.50Low
5/16/2023Stifel NicolausBoost Target$95.00 ➝ $105.00Low
5/15/2023Wells Fargo & CompanyBoost Target$88.75 ➝ $107.50Low
4/18/2023MizuhoBoost Target$97.50 ➝ $100.00Low
4/3/2023CitigroupBoost TargetBuy$93.00 ➝ $107.50Low
3/3/2023Robert W. BairdBoost Target$92.75 ➝ $96.25Low
3/3/2023MizuhoBoost Target$96.25 ➝ $97.50Low
1/24/2023MizuhoBoost TargetBuy$93.75 ➝ $96.25Low
1/11/2023Piper SandlerBoost TargetOverweight$87.50 ➝ $93.75Low
12/22/2022MizuhoInitiated CoverageBuy$93.75Low
12/12/2022CitigroupBoost TargetBuy$87.00 ➝ $92.00Low
12/9/2022Robert W. BairdLower TargetOutperform$92.50 ➝ $88.75Low
12/9/2022Piper SandlerLower Target$88.75 ➝ $87.50N/A
11/30/2022Robert W. BairdUpgradeNeutral ➝ Outperform$86.25 ➝ $93.75Low
11/28/2022JPMorgan Chase & Co.Boost Target$75.00 ➝ $82.50Low
11/3/2022Piper SandlerLower TargetOverweight$93.75 ➝ $88.75Low
10/11/2022Jefferies Financial GroupDowngradeBuy ➝ Hold$100.00 ➝ $73.75Low
10/5/2022CitigroupLower Target$87.50 ➝ $87.00Low
9/1/2022Wells Fargo & CompanyLower TargetOverweight$92.50 ➝ $91.25Low
9/1/2022Robert W. BairdLower TargetNeutral$93.75 ➝ $86.25Low
9/1/2022CitigroupLower TargetBuy$101.50 ➝ $87.50Low
8/24/2022Robert W. BairdLower TargetNeutral$98.00 ➝ $93.75Low
8/10/2022Wells Fargo & CompanyLower TargetOverweight$95.00 ➝ $92.50Low
7/8/2022Piper SandlerLower TargetOverweight$106.25 ➝ $93.75N/A
6/6/2022CitigroupBoost TargetBuy$101.25 ➝ $101.50Low
6/6/2022Stifel NicolausLower Target$118.75 ➝ $112.50Low
6/3/2022StephensLower TargetOverweight$125.00 ➝ $115.00Medium
6/3/2022KeyCorpLower TargetOverweight$103.50 ➝ $102.00Low
5/31/2022Piper SandlerLower TargetOverweight$125.00 ➝ $107.50Medium
5/26/2022Robert W. BairdLower Target$109.25 ➝ $98.00Low
5/25/2022KeyCorpLower TargetOverweight$114.75 ➝ $103.50Low
5/23/2022Wells Fargo & CompanyLower TargetOverweight$123.75 ➝ $95.00Low
5/17/2022CitigroupUpgradeNeutral ➝ Buy$115.00 ➝ $101.25N/A
4/8/2022Needham & Company LLCInitiated CoverageHoldMedium
3/7/2022StephensBoost TargetOverweight$107.50 ➝ $125.00High
3/4/2022Piper SandlerBoost Target$122.50 ➝ $125.00High
1/3/2022GuggenheimUpgradeNeutral ➝ Buy$123.75Medium
12/3/2021Robert W. BairdReiterated RatingHold$107.75N/A
12/3/2021CitigroupLower TargetNeutral$113.25 ➝ $106.25High
12/3/2021KeyCorpLower TargetOverweight$116.25 ➝ $114.75High
10/21/2021KeyCorpLower TargetOverweight$119.00 ➝ $116.25Low
9/3/2021Robert W. BairdReiterated RatingHold$105.75High
9/3/2021Stifel NicolausBoost TargetBuy$112.50 ➝ $118.75High
9/3/2021CitigroupBoost TargetNeutral$100.00 ➝ $113.25High
9/3/2021OppenheimerBoost TargetPositive ➝ Outperform$101.25 ➝ $118.75High
9/3/2021KeyCorpBoost TargetOverweight$111.00 ➝ $119.00High
8/19/2021Wells Fargo & CompanyBoost TargetOverweight$111.25 ➝ $120.00Medium
8/6/2021Piper SandlerBoost TargetOverweight$110.00 ➝ $115.00Low
7/16/2021StephensBoost TargetOverweight$107.50 ➝ $112.50Low
7/1/2021Stifel NicolausBoost TargetBuy$101.25 ➝ $112.50Medium
6/1/2021Piper SandlerBoost TargetOverweight$108.75 ➝ $110.00Medium
5/24/2021Jefferies Financial GroupReiterated RatingBuy$112.50Low
4/28/2021KeyCorpBoost TargetOverweight$107.25 ➝ $111.00Low
4/23/2021Redburn PartnersInitiated CoverageBuyMedium
3/8/2021KeyCorpBoost TargetOverweight$106.25 ➝ $107.25Medium
3/5/2021CitigroupBoost TargetNeutral$88.75 ➝ $94.50High
3/5/2021Jefferies Financial GroupBoost TargetBuy$106.25 ➝ $108.75High
3/5/2021Raymond JamesBoost TargetOutperform$93.75 ➝ $103.75High
3/5/2021Robert W. BairdBoost TargetNeutral$87.75 ➝ $96.00High
3/1/2021KeyCorpBoost TargetOverweight$106.25 ➝ $107.25Low
2/23/2021KeyCorpBoost TargetOverweight$99.00 ➝ $106.25Low
2/11/2021Piper SandlerBoost TargetOverweight$92.50 ➝ $108.75Low
1/25/2021Wells Fargo & CompanyBoost Target$103.75 ➝ $111.25Medium
1/8/2021KeyCorpBoost TargetOverweight$91.75 ➝ $99.00Medium
12/4/2020Smith Barney CitigroupBoost Target$82.50 ➝ $83.75Medium
12/4/2020Piper SandlerBoost TargetOverweight$87.75 ➝ $92.50High
12/4/2020KeyCorpBoost TargetOverweight$87.25 ➝ $91.75High
11/20/2020Wells Fargo & CompanyBoost TargetOverweight$90.00 ➝ $95.00Low
9/24/2020OppenheimerReiterated RatingHoldLow
9/17/2020Raymond JamesBoost TargetPositive ➝ Outperform$82.50 ➝ $93.75Medium
9/4/2020JPMorgan Chase & Co.Boost TargetNeutral$71.25 ➝ $78.75High
9/4/2020OppenheimerBoost TargetMarket Perform$82.50 ➝ $85.00High
9/4/2020Raymond JamesReiterated RatingBuyHigh
9/4/2020StephensBoost TargetOverweight$81.25 ➝ $91.25High
9/4/2020CitigroupBoost TargetNeutral$77.50 ➝ $82.50High
9/4/2020KeyCorpBoost TargetPositive ➝ Overweight$82.50 ➝ $87.25High
7/6/2020Robert W. BairdDowngradeOutperform ➝ Neutral$83.75 ➝ $72.75High
6/5/2020OppenheimerInitiated CoverageHold$82.50Low
6/5/2020Raymond JamesLower TargetOutperform$85.00 ➝ $82.50High
5/26/2020StephensBoost TargetOverweight$75.00 ➝ $81.25High
5/26/2020KeyCorpLower TargetOverweight$95.00 ➝ $82.50High
5/21/2020Wells Fargo & CompanyLower TargetOverweight$97.00 ➝ $82.25High
4/21/2020Raymond JamesLower TargetOutperform$90.00 ➝ $85.00High
4/8/2020Jefferies Financial GroupLower TargetBuy$90.00 ➝ $85.00High
3/27/2020CitigroupLower TargetNeutral$90.00 ➝ $79.50Medium
3/23/2020StephensLower TargetOverweight$93.75 ➝ $75.00Low
3/6/2020Piper SandlerBoost Target$86.00 ➝ $87.75High
3/6/2020Stifel NicolausBoost TargetBuy$80.00 ➝ $87.50High
3/6/2020Robert W. BairdBoost TargetOutperform$86.25 ➝ $89.25High
3/6/2020StephensBoost TargetOverweight$85.00 ➝ $93.75High
3/6/2020Raymond JamesBoost TargetOutperform$88.75 ➝ $90.00High
3/4/2020CitigroupInitiated CoverageNeutral$90.00High
1/22/2020KeyCorpBoost TargetOverweight$87.75 ➝ $95.00Low
1/16/2020Wells Fargo & CompanyBoost TargetOverweight$90.00 ➝ $97.00Medium
12/6/2019Piper Sandler CompaniesReiterated RatingBuy$86.00Low
12/6/2019Robert W. BairdReiterated RatingBuy$86.25Low
12/6/2019Raymond JamesLower TargetBuy ➝ In-Line$91.00 ➝ $88.75High
12/4/2019Jefferies Financial GroupLower TargetAverage ➝ In-Line$89.50 ➝ $82.50Low
12/3/2019Northcoast ResearchReiterated RatingBuyLow
11/27/2019KeyCorpBoost TargetOverweight$87.00 ➝ $87.75Low
10/11/2019KeyCorpLower TargetOverweight$87.75 ➝ $87.00Low
8/30/2019Piper Sandler CompaniesSet TargetBuy$90.00Medium
8/30/2019KeyCorpSet TargetBuy$87.75Medium
8/26/2019Raymond JamesReiterated RatingBuyLow
8/22/2019KeyCorpBoost TargetOverweight ➝ Overweight$78.50 ➝ $87.75Low
8/13/2019Piper Sandler CompaniesBoost TargetOverweight$82.50 ➝ $90.00Medium
8/8/2019Wells Fargo & CompanyBoost TargetOutperform$89.00 ➝ $91.25Low
(Data available from 7/15/2019 forward)

News Sentiment Rating

1.38 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 20 very positive mentions
  • 23 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
12/18/2023
  • 10 very positive mentions
  • 12 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
1/17/2024
  • 12 very positive mentions
  • 22 positive mentions
  • 4 negative mentions
  • 2 very negative mentions
2/16/2024
  • 10 very positive mentions
  • 28 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
3/17/2024
  • 7 very positive mentions
  • 24 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
4/16/2024
  • 4 very positive mentions
  • 22 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
5/16/2024
  • 20 very positive mentions
  • 13 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
6/15/2024
  • 27 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
7/15/2024

Current Sentiment

  • 27 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Cooper Companies logo
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Read More

Today's Range

Now: $90.81
Low: $88.65
High: $91.60

50 Day Range

MA: $92.06
Low: $85.51
High: $97.90

52 Week Range

Now: $90.81
Low: $75.93
High: $104.07

Volume

1,609,400 shs

Average Volume

1,119,726 shs

Market Capitalization

$18.08 billion

P/E Ratio

53.34

Dividend Yield

N/A

Beta

0.98

Frequently Asked Questions

What sell-side analysts currently cover shares of Cooper Companies?

The following Wall Street analysts have issued research reports on Cooper Companies in the last twelve months: Bank of America Co., Citigroup Inc., JPMorgan Chase & Co., KeyCorp, Mizuho, Morgan Stanley, Needham & Company LLC, Piper Sandler, Redburn Atlantic, Robert W. Baird, Stifel Nicolaus, StockNews.com, and TheStreet.
View the latest analyst ratings for COO.

What is the current price target for Cooper Companies?

9 Wall Street analysts have set twelve-month price targets for Cooper Companies in the last year. Their average twelve-month price target is $111.42, suggesting a possible upside of 22.7%. Redburn Atlantic has the highest price target set, predicting COO will reach $125.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $88.75 for Cooper Companies in the next year.
View the latest price targets for COO.

What is the current consensus analyst rating for Cooper Companies?

Cooper Companies currently has 3 hold ratings and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for COO.

What other companies compete with Cooper Companies?

How do I contact Cooper Companies' investor relations team?

Cooper Companies' physical mailing address is 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583. The medical device company's listed phone number is (925) 460-3600 and its investor relations email address is [email protected]. The official website for Cooper Companies is www.coopercos.com. Learn More about contacing Cooper Companies investor relations.